Federal contract award
6913G625C100023
LEGACY INNOVATION INC. PHASE II SBIR UNDER TOPIC 24-NH5: PREHOSPITAL BLOOD TRANSFUSION SYSTEMS IMPROVEMENT: EXPANDING ACCESS THROUGH INNOVATIVE TECHNOLOGIES AND TOOLS
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Transportation |
| Office | 6913G6 VOLPE NATL. TRANS. SYS CNTR |
| NAICS | 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| PSC | AS12 — TRANSPORTATION R&D SERVICES; SURFACE TRANSPORTATION, PUBLIC TRANSIT, AND RAIL; APPLIED RESEARCH |
| Parent award / vehicle | Not reported |
| Set-aside | SMALL BUSINESS SET ASIDE - TOTAL |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $1.3M |
| Current contract value | $1.3M |
| Potential contract value / ceiling | $1.3M |
| Start date | Sep 26, 2025 |
| Current end date | Sep 25, 2027 |
| Potential end date | Sep 25, 2027 |
| Latest award activity | Aug 13, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 5 of 5 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Aug 13, 2026 | P00004 | $0 | LEGACY INNOVATION INC. PHASE II SBIR TOPIC 24-NH5: PREHOSPITAL BLOOD TRANSFUSION SYSTEMS IMPROVEMENT: EXPANDING ACCESS THROUGH INNOVATIVE TECHNOLOGIES AND TOOLS. MOD TO INCLUDE QUANTITY, UNIT, AND UNIT PRICE FOR NEW CLIN ADDED VIA MOD P00003. |
| Aug 5, 2026 | P00003 | $13.0K | LEGACY INNOVATON INC. PHASE II SBIR TOPIC 24-NH5: PREHOSPITAL BLOOD TRANSFUSION SYSTEMS IMPROVEMENT: EXPANDING ACCESS THROUGH INNOVATIVE TECHNOLOGIES AND TOOLS. MOD TO INCREASE CONTRACT VALUE ADDING NEW CLIN FOR TECH AND BUS. ASST (TABA) SERVICES. |
| Jul 20, 2026 | P00002 | $0 | LEGACY INNOVATION INC. PHASE II SBIR UNDER TOPIC 24-NH5: PREHOSPITAL BLOOD TRANSFUSION SYSTEMS IMPROVEMENT: EXPANDING ACCESS THROUGH INNOVATIVE TECHNOLOGIES AND TOOLS. ADD FAR CLAUSE 52.222-90 IN FULL TEXT. |
| Jan 12, 2026 | P00001 | $0 | LEGACY INNOVATION INC. PHASE II SBIR UNDER TOPIC 24-NH5: PREHOSPITAL BLOOD TRANSFUSION SYSTEMS IMPROVEMENT: EXPANDING ACCESS THROUGH INNOVATIVE TECHNOLOGIES AND TOOLS. MODIFICATION TO CORRECT POP START AND END DATES. |
| Sep 26, 2025 | 0 | $1.2M | LEGACY INNOVATION INC. PHASE II SBIR UNDER TOPIC 24-NH5: PREHOSPITAL BLOOD TRANSFUSION SYSTEMS IMPROVEMENT: EXPANDING ACCESS THROUGH INNOVATIVE TECHNOLOGIES AND TOOLS |
Estimated positioning window
Oct 25, 2026 – Mar 25, 2027
80/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 80/100. Available recorded signals: 75 points.
- Contract end 2027-09-25 (335 days from calculation)
- +35 points
- 81 historical awards in this buyer and category group
- +15 points
- 5 recorded award transactions
- +10 points
- Latest award action: 2026-08-13
- +5 points
- Parent award identifier recorded
- +0 points
- Solicitation identifier recorded
- +10 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-10-25 10:18:04.631876+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Oct 25, 2026.
Buyer contacts from matching notices
Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.